These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 30809696

  • 1. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S, Ji X, Wang R, Miao Y.
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
    Miao Y, Lu M, Yan Q, Li S, Feng Y.
    Oncol Res; 2016 Oct 27; 24(6):463-475. PubMed ID: 28281967
    [Abstract] [Full Text] [Related]

  • 3. iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer.
    Li L, Zhu L, Hao B, Gao W, Wang Q, Li K, Wang M, Huang M, Liu Z, Yang Q, Li X, Zhong Z, Huang W, Xiao G, Xu Y, Yao K, Liu Q.
    Oncotarget; 2017 May 16; 8(20):33047-33063. PubMed ID: 28380434
    [Abstract] [Full Text] [Related]

  • 4. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y, Zhang J, Zhu Y, Zhang Z, Sun H, Feng Y.
    Int J Gynecol Cancer; 2014 Nov 16; 24(9):1564-74. PubMed ID: 25340291
    [Abstract] [Full Text] [Related]

  • 5. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Nov 16; 51(3):1340-1353. PubMed ID: 30481782
    [Abstract] [Full Text] [Related]

  • 6. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
    Perez-Juarez CE, Arechavaleta-Velasco F, Mendez C, Díaz-Cueto L.
    Med Oncol; 2020 May 30; 37(7):59. PubMed ID: 32474861
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B, Liu F, Zeng L, Geng L, Ouyang X, Wang K, Huang Q.
    Med Sci Monit; 2018 May 12; 24():3103-3112. PubMed ID: 29752805
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
    Sheng L, Liu DY, Shen K.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec 12; 38(12):752-5. PubMed ID: 14728848
    [Abstract] [Full Text] [Related]

  • 13. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z, Yang P, Li Z.
    Biochim Biophys Acta; 2014 Dec 12; 1846(2):285-96. PubMed ID: 25064846
    [Abstract] [Full Text] [Related]

  • 14. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Xu CL, Lu XL, Yan XN, Wang HL, Chen SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb 12; 47(2):134-8. PubMed ID: 22455747
    [Abstract] [Full Text] [Related]

  • 15. TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer.
    Chen M, Sheng XJ, Qin YY, Zhu S, Wu QX, Jia L, Meng N, He YT, Yan GR.
    Theranostics; 2019 Feb 12; 9(3):676-690. PubMed ID: 30809301
    [Abstract] [Full Text] [Related]

  • 16. Aqueous Extract of Rhubarb Promotes Hepatotoxicity via Facilitating PKM2-Mediated Aerobic Glycolysis in a Rat Model of Diethylnitrosamine-Induced Liver Cancer.
    Zhao A, Liu X, Chen X, Na S, Wang H, Peng X, Kong P, Li L.
    Drug Des Devel Ther; 2024 Feb 12; 18():4497-4510. PubMed ID: 39403095
    [Abstract] [Full Text] [Related]

  • 17. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A, Xiang Y, Si YR, Fan LJ, Li JP, Li H, Guo W, He HX, Liang XJ, Tan Y, Bao LY, Liao XH.
    J Cell Biochem; 2019 Apr 12; 120(4):6542-6554. PubMed ID: 30368881
    [Abstract] [Full Text] [Related]

  • 18. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
    Li T, Han J, Jia L, Hu X, Chen L, Wang Y.
    Protein Cell; 2019 Aug 12; 10(8):583-594. PubMed ID: 30887444
    [Abstract] [Full Text] [Related]

  • 19. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z, Wang Z, Guo W, Zhang Z, Zhao F, Zhao Y, Jia D, Ding J, Wang H, Yao M, He X.
    Oncogene; 2015 Jul 23; 34(30):3946-56. PubMed ID: 25263439
    [Abstract] [Full Text] [Related]

  • 20. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K.
    Mol Cancer; 2017 Dec 20; 16(1):178. PubMed ID: 29262861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.